Click on image to view larger version.
Figure 3. (a) The lesion in segment V appeared echogenic. (b) After administration of Levovist (Schering AG, Berlin, Germany), using a microbubble specific mode (ADI; Acuson Inc., Mountain View, CA), minimal activity is shown on ultrasound within the segment V lesion (arrowhead). Note the "bright" normal liver parenchyma, which demonstrates uptake of microbubble contrast agent (arrow). (c) Transverse ultrasound image of the lesion post-contrast, again demonstrating minimal activity using ADI mode (arrow).
